Upgrades
Barclays upgraded the previous rating for Gap Inc (NYSE:GPS) from Underweight to Equal-Weight. Gap earned $0.08 in the second quarter, compared to $0.70 in the year-ago quarter. The current stock performance of Gap shows a 52-week-high of $19.06 and a 52-week-low of $7.79. Moreover, at the end of the last trading period, the closing price was at $9.67.
For PayPal Holdings Inc (NASDAQ:PYPL), B of A Securities upgraded the previous rating of Neutral to Buy. PayPal Holdings earned $0.93 in the second quarter, compared to $1.15 in the year-ago quarter. At the moment, the stock has a 52-week-high of $196.10 and a 52-week-low of $67.58. PayPal Holdings closed at $91.80 at the end of the last trading period.
According to Cowen & Co., the prior rating for Rocket Lab USA Inc (NASDAQ:RKLB) was changed from Market Perform to Outperform. The stock has a 52-week-high of $12.33 and a 52-week-low of $3.53. At the end of the last trading period, Rocket Lab USA closed at $5.13.
See all analyst ratings upgrades.
Downgrades
For Ambarella Inc (NASDAQ:AMBA), Summit Insights Group downgraded the previous rating of Buy to Hold. For the second quarter, Ambarella had an EPS of $0.20, compared to year-ago quarter EPS of $0.35. At the moment, the stock has a 52-week-high of $220.14 and a 52-week-low of $60.56. Ambarella closed at $84.50 at the end of the last trading period.
According to B of A Securities, the prior rating for JOANN Inc (NASDAQ:JOAN) was changed from Neutral to Underperform. For the first quarter, JOANN had an EPS of $0.22, compared to year-ago quarter EPS of $0.46. At the moment, the stock has a 52-week-high of $13.55 and a 52-week-low of $6.23. JOANN closed at $7.95 at the end of the last trading period.
Barclays downgraded the previous rating for Robinhood Markets Inc (NASDAQ:HOOD) from Equal-Weight to Underweight. Robinhood Markets earned $0.34 in the second quarter, compared to $2.16 in the year-ago quarter. At the moment, the stock has a 52-week-high of $18.94 and a 52-week-low of $6.81. Robinhood Markets closed at $9.47 at the end of the last trading period.
BTIG downgraded the previous rating for Redwood Trust Inc (NYSE:RWT) from Buy to Neutral. In the second quarter, Redwood Trust showed an EPS of $0.11, compared to $0.66 from the year-ago quarter. The current stock performance of Redwood Trust shows a 52-week-high of $13.69 and a 52-week-low of $6.57. Moreover, at the end of the last trading period, the closing price was at $7.87.
Citigroup downgraded the previous rating for Snap Inc (NYSE:SNAP) from Buy to Neutral. Snap earned $0.02 in the second quarter, compared to $0.10 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.71 and a 52-week-low of $9.34. Snap closed at $10.01 at the end of the last trading period.
Susquehanna downgraded the previous rating for Paysafe Ltd (NYSE:PSFE) from Positive to Neutral. Paysafe earned $0.05 in the second quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $4.37 and a 52-week-low of $1.72. At the end of the last trading period, Paysafe closed at $1.82.
Veritas Research downgraded the previous rating for Bank of Montreal (NYSE:BMO) from Buy to Reduce. Bank of Montreal earned $2.40 in the third quarter, compared to $2.80 in the year-ago quarter. The stock has a 52-week-high of $122.77 and a 52-week-low of $90.44. At the end of the last trading period, Bank of Montreal closed at $94.98.
See all analyst ratings downgrades.
Initiations
With a Buy rating, Jefferies initiated coverage on Cadre Holdings Inc (NYSE:CDRE). The price target seems to have been set at $32.00 for Cadre Hldgs. The stock has a 52-week-high of $28.49 and a 52-week-low of $17.74. At the end of the last trading period, Cadre Hldgs closed at $25.79.
With a Buy rating, Ladenburg Thalmann initiated coverage on Satsuma Pharmaceuticals Inc (NASDAQ:STSA). The price target seems to have been set at $16.00 for Satsuma Pharmaceuticals. For the second quarter, Satsuma Pharmaceuticals had an EPS of $0.52, compared to year-ago quarter EPS of $0.38. The current stock performance of Satsuma Pharmaceuticals shows a 52-week-high of $6.55 and a 52-week-low of $2.51. Moreover, at the end of the last trading period, the closing price was at $6.32.
With an Overweight rating, Stephens & Co. initiated coverage on CrowdStrike Holdings Inc (NASDAQ:CRWD). The price target seems to have been set at $236.00 for CrowdStrike Holdings. In the second quarter, CrowdStrike Holdings showed an EPS of $0.36, compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $242.00 and a 52-week-low of $130.00. At the end of the last trading period, CrowdStrike Holdings closed at $193.29.
Janney Montgomery Scott initiated coverage on Shore Bancshares Inc (NASDAQ:SHBI) with a Neutral rating. Shore Bancshares earned $0.39 in the second quarter, compared to $0.34 in the year-ago quarter. The current stock performance of Shore Bancshares shows a 52-week-high of $21.41 and a 52-week-low of $17.91. Moreover, at the end of the last trading period, the closing price was at $19.27.
Barclays initiated coverage on Interactive Brokers Group Inc (NASDAQ:IBKR) with an Overweight rating. The price target for Interactive Brokers Gr is set to $77.00. For the second quarter, Interactive Brokers Gr had an EPS of $0.84, compared to year-ago quarter EPS of $0.82. The current stock performance of Interactive Brokers Gr shows a 52-week-high of $80.96 and a 52-week-low of $52.18. Moreover, at the end of the last trading period, the closing price was at $60.74.
With a Equal-Weight rating, Barclays initiated coverage on Coinbase Global Inc (NASDAQ:COIN). The price target seems to have been set at $80.00 for Coinbase Global. In the second quarter, Coinbase Global showed an EPS of $4.98, compared to $6.42 from the year-ago quarter. The stock has a 52-week-high of $258.81 and a 52-week-low of $40.83. At the end of the last trading period, Coinbase Global closed at $67.03.
With an Overweight rating, Barclays initiated coverage on Ares Management Corp (NYSE:ARES). The price target seems to have been set at $92.00 for Ares Management. In the second quarter, Ares Management showed an EPS of $0.74, compared to $0.64 from the year-ago quarter. At the moment, the stock has a 52-week-high of $85.48 and a 52-week-low of $53.15. Ares Management closed at $73.53 at the end of the last trading period.
With an Overweight rating, Barclays initiated coverage on Apollo Global Management Inc (NYSE:APO). The price target seems to have been set at $70.00 for Apollo Global Management. In the second quarter, Apollo Global Management showed an EPS of $0.94, compared to $1.14 from the year-ago quarter. The stock has a 52-week-high of $74.44 and a 52-week-low of $45.97. At the end of the last trading period, Apollo Global Management closed at $54.95.
With an Overweight rating, Barclays initiated coverage on P10 Inc (NYSE:PX). The price target seems to have been set at $15.00 for P10. The current stock performance of P10 shows a 52-week-high of $14.19 and a 52-week-low of $10.09. Moreover, at the end of the last trading period, the closing price was at $12.47.
Barclays initiated coverage on StepStone Group Inc (NASDAQ:STEP) with a Equal-Weight rating. The price target for StepStone Group is set to $33.00. In the first quarter, StepStone Group showed an EPS of $0.41, compared to $0.41 from the year-ago quarter. The current stock performance of StepStone Group shows a 52-week-high of $42.33 and a 52-week-low of $22.39. Moreover, at the end of the last trading period, the closing price was at $27.23.
With a Equal-Weight rating, Barclays initiated coverage on Charles Schwab Corp (NYSE:SCHW). The price target seems to have been set at $81.00 for Charles Schwab. For the second quarter, Charles Schwab had an EPS of $0.97, compared to year-ago quarter EPS of $0.70. At the moment, the stock has a 52-week-high of $96.24 and a 52-week-low of $59.35. Charles Schwab closed at $72.50 at the end of the last trading period.
For Bicycle Therapeutics PLC (NASDAQ:BCYC), Cowen & Co. initiated coverage, by setting the current rating at Outperform. Bicycle Therapeutics earned $0.90 in the second quarter, compared to $0.74 in the year-ago quarter. The current stock performance of Bicycle Therapeutics shows a 52-week-high of $60.80 and a 52-week-low of $12.08. Moreover, at the end of the last trading period, the closing price was at $25.37.
With a Buy rating, UBS initiated coverage on LSB Industries Inc (NYSE:LXU). The price target seems to have been set at $20.00 for LSB Industries. For the second quarter, LSB Industries had an EPS of $1.22, compared to year-ago quarter EPS of $0.09. The stock has a 52-week-high of $27.45 and a 52-week-low of $9.06. At the end of the last trading period, LSB Industries closed at $15.28.
With a Buy rating, BTIG initiated coverage on Shattuck Labs Inc (NASDAQ:STTK). The price target seems to have been set at $12.00 for Shattuck Labs. In the second quarter, Shattuck Labs showed an EPS of $0.65, compared to $0.56 from the year-ago quarter. The stock has a 52-week-high of $9.46 and a 52-week-low of $2.59. At the end of the last trading period, Shattuck Labs closed at $3.03.
Benchmark initiated coverage on Landstar System Inc (NASDAQ:LSTR) with a Hold rating. For the second quarter, Landstar System had an EPS of $3.05, compared to year-ago quarter EPS of $2.40. At the moment, the stock has a 52-week-high of $182.00 and a 52-week-low of $137.15. Landstar System closed at $148.46 at the end of the last trading period.
With a Buy rating, HC Wainwright & Co. initiated coverage on AgriFORCE Growing Systems Ltd (NASDAQ:AGRI). The price target seems to have been set at $5.50 for AgriFORCE Growing Systems. The current stock performance of AgriFORCE Growing Systems shows a 52-week-high of $6.10 and a 52-week-low of $1.12. Moreover, at the end of the last trading period, the closing price was at $1.74.
With a Buy rating, BTIG initiated coverage on Signify Health Inc (NYSE:SGFY). The price target seems to have been set at $35.00 for Signify Health. Signify Health earned $0.85 in the second quarter, compared to $0.00 in the year-ago quarter. The stock has a 52-week-high of $29.88 and a 52-week-low of $10.70. At the end of the last trading period, Signify Health closed at $27.59.
With an Overweight rating, Piper Sandler initiated coverage on Miromatrix Medical Inc (NASDAQ:MIRO). The price target seems to have been set at $8.00 for Miromatrix Medical. In the second quarter, Miromatrix Medical showed an EPS of $0.40, compared to $1.27 from the year-ago quarter. At the moment, the stock has a 52-week-high of $5.29 and a 52-week-low of $2.02. Miromatrix Medical closed at $2.92 at the end of the last trading period.
